| Size | Price | |
|---|---|---|
| 500mg | ||
| 1g | ||
| Other Sizes |
| ln Vitro |
In P32-orthophosphate-labeled cells, CYM5442 (0.5 µM; 0–60 min; HEK293 cells) treatment induces S1P1 phosphorylation in a time-dependent manner [1]. In S1P1-transfected CHO-K1 cells, CYM5442 with an EC50 of 46 nM stimulates S1P1-dependent p42/p44-MAPK phosphorylation. When CYM5442 was added to the R120 alanine (R120A) mutant, it was still possible to sustain p42/p44-MAPK activity (EC50 of 67 nM). In E121A S1P1 cells, CYM-5442 activates p42/p44-MAPK in a concentration-dependent manner, with an average EC50 value of 134 nM [1].
|
|---|---|
| ln Vivo |
Adult male albino Wistar rats treated with CYM5442 (1 mg/kg; intraperitoneal; daily; for 5 days) demonstrated preservation of visual function at the visual evoked potential (VEP). When CYM was administered to mice instead of a vehicle, the retinal nerve fiber layer (RNFL) was noticeably thicker [2].
|
| Cell Assay |
Western Blot Analysis[1]
Cell Types: HEK293 cells stably expressing S1P1 fused to GFP at the carboxyl terminus Tested Concentrations: 0.5 µM Incubation Duration: 0 min, 2 min, 5 min, 10 min, 30 min, 60 min Experimental Results: Stimulated S1P1 is phosphorylated in a time-dependent manner. |
| Animal Protocol |
Animal/Disease Models: Adult male albino Wistar rats (8-10 weeks old; 180-230 g) infected ocular endothelin-1 (ET-1) [2]
Doses: 1 mg/kg Route of Administration: intraperitoneal (ip) injection; Routine; continued for 5 days Experimental Results: Visual evoked potentials (VEP) demonstrated preservation of visual function. The number of retinal ganglion cells (RGC) increased Dramatically. |
| References |
|
| Molecular Formula |
C23H28CLN3O4
|
|---|---|
| Molecular Weight |
445.939125061035
|
| Exact Mass |
445.176
|
| CAS # |
1783987-80-3
|
| Related CAS # |
CYM5442;1094042-01-9
|
| PubChem CID |
90488865
|
| Appearance |
Typically exists as solid at room temperature
|
| Hydrogen Bond Donor Count |
3
|
| Hydrogen Bond Acceptor Count |
7
|
| Rotatable Bond Count |
9
|
| Heavy Atom Count |
31
|
| Complexity |
525
|
| Defined Atom Stereocenter Count |
0
|
| InChi Key |
KMZLVDAVGXYZDA-UHFFFAOYSA-N
|
| InChi Code |
InChI=1S/C23H27N3O4.ClH/c1-3-28-20-11-8-15(14-21(20)29-4-2)23-25-22(26-30-23)18-7-5-6-17-16(18)9-10-19(17)24-12-13-27;/h5-8,11,14,19,24,27H,3-4,9-10,12-13H2,1-2H3;1H
|
| Chemical Name |
2-[[4-[5-(3,4-diethoxyphenyl)-1,2,4-oxadiazol-3-yl]-2,3-dihydro-1H-inden-1-yl]amino]ethanol;hydrochloride
|
| Synonyms |
CYM 5442 HCl; CYM-5442 HCl
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
May dissolve in DMSO (in most cases), if not, try other solvents such as H2O, Ethanol, or DMF with a minute amount of products to avoid loss of samples
|
|---|---|
| Solubility (In Vivo) |
Note: Listed below are some common formulations that may be used to formulate products with low water solubility (e.g. < 1 mg/mL), you may test these formulations using a minute amount of products to avoid loss of samples.
Injection Formulations
Injection Formulation 1: DMSO : Tween 80： Saline = 10 : 5 : 85 (i.e. 100 μL DMSO stock solution → 50 μL Tween 80 → 850 μL Saline)(e.g. IP/IV/IM/SC) *Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH ₂ O to obtain a clear solution. Injection Formulation 2: DMSO : PEG300 ：Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL DMSO → 400 μLPEG300 → 50 μL Tween 80 → 450 μL Saline) Injection Formulation 3: DMSO : Corn oil = 10 : 90 (i.e. 100 μL DMSO → 900 μL Corn oil) Example: Take the Injection Formulation 3 (DMSO : Corn oil = 10 : 90) as an example, if 1 mL of 2.5 mg/mL working solution is to be prepared, you can take 100 μL 25 mg/mL DMSO stock solution and add to 900 μL corn oil, mix well to obtain a clear or suspension solution (2.5 mg/mL, ready for use in animals). View More
Injection Formulation 4: DMSO : 20% SBE-β-CD in saline = 10 : 90 [i.e. 100 μL DMSO → 900 μL (20% SBE-β-CD in saline)] Oral Formulations
Oral Formulation 1: Suspend in 0.5% CMC Na (carboxymethylcellulose sodium) Oral Formulation 2: Suspend in 0.5% Carboxymethyl cellulose Example: Take the Oral Formulation 1 (Suspend in 0.5% CMC Na) as an example, if 100 mL of 2.5 mg/mL working solution is to be prepared, you can first prepare 0.5% CMC Na solution by measuring 0.5 g CMC Na and dissolve it in 100 mL ddH2O to obtain a clear solution; then add 250 mg of the product to 100 mL 0.5% CMC Na solution, to make the suspension solution (2.5 mg/mL, ready for use in animals). View More
Oral Formulation 3: Dissolved in PEG400 (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.2425 mL | 11.2123 mL | 22.4245 mL | |
| 5 mM | 0.4485 mL | 2.2425 mL | 4.4849 mL | |
| 10 mM | 0.2242 mL | 1.1212 mL | 2.2425 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
